From Fighting Cancer to Opioid Addiction – Genes Matter with Meds

813 views · Published 6 October 2017 · 2:45 · Indexed 4 November 2026

Channel: Mayo Clinic · 2017 · Science & Technology

Watch on YouTube

A gathering of experts is meeting at Mayo Civic Center October 9 and 10 to talk about why a medication that works for one person may be ineffective for another. It's all in the genes. Individualizing Medicine 2017: Advancing Care Through Genomics is a two day conference hosted by the Mayo Clinic Center for Individualized Medicine.

Topics range from genetic testing's value in diagnosing and treating a host of diseases, including cancer, cardiovascular and neurologic conditions - to the growing practice of precisely matching specific medications to a body's ability to process them correctly to get their full benefit. "This is really a hot topic right now," says Dr. Timothy Curry, a Mayo Clinic anesthesiologist and researcher who will be one of the conference speakers.

The field of studying and applying the knowledge of genetic variations to the use of pharmaceutical drugs is known as pharmacogenomics and Dr. Curry says it has the potential to benefit virtually everyone. "What we know from early studies here at Mayo clinic is that, if you looked at just five genes, 99 percent of people would have something in one of those genes that would affect their medications."

Understanding these individual genetic differences among patients may even be beneficial in preventing and treating opioid addiction, a problem that has been declared a national crisis.

More health and medical news on the Mayo Clinic News Network http://newsnetwork.mayoclinic.org/

More from this channel